The firm hopes to exploit its first-mover advantage in the OTC space following de novo clearance for an at-home PCR test to detect sexually transmitted infections.
Danaher Corporation ( NYSE: DHR) Q3 2025 Earnings Call October 21, 2025 8:00 AM EDT ...
HSV Testing Market Set for Transformative Growth: Opportunities for Manufacturers to Lead Innovation
The expansion of the HSV testing market is being fueled by a combination of increasing prevalence of HSV infections, ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...
Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s ...
MedPage Today on MSN
Add-On Multicancer Early Detection Test Promising Across Various Cancer Types
BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...
The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...
A Labcorp team member draws blood from a patient.Labcorp Labcorp, one of the country’s largest providers of diagnostic ...
Everyday Health on MSN
New Blood Test to Rule Out Alzheimer’s Gets FDA Clearance
The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...
"Cepheids don't pulse at the same rate, but rather at a rate proportional to their brightness, which means that from an ...
Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback